STANDARD BIOTOOLS INC.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On March 10, 2022, Colin McCracken, the Chief Commercial Officer of Fluidigm Corporation (the “Company”), notified the Company of his intention to resign, effective as of June 12, 2022, after assisting with the Company’s transition plan with respect to his role and responsibilities.
Extracted from this filing and checked against the source text.
Colin McCracken resigned as Chief Commercial Officer at STANDARD BIOTOOLS INC..
On March 10, 2022, Colin McCracken, the Chief Commercial Officer of Fluidigm Corporation (the “Company”), notified the Company of his intention to resign, effective as of June 12, 2022, after assisting with the Company’s transition plan with respect to his role and responsibilities.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.